Want to know if you had COVID-19?

T cells have the answer.

T-Detect COVID has been shown to have high sensitivity, however in certain circumstances, the test may be negative despite a prior SARS-CoV-2 infection.

Want to know if you had COVID-19?

T cells have the answer.

T-Detect COVID has been shown to have high sensitivity, however in certain circumstances, the test may be negative despite a prior SARS-CoV-2 infection.

Special self-pay test price $150

Additional fees include test authorization ($9) and blood draw
(on-site lab: $60 or in-home: $140).

Order Now

The price does not represent the usual and customary charge for the T-Detect COVID test and is subject to change. The T-Detect COVID test is FSA/HSA eligible. It is not currently available in the state of New York. 

How it works

1. Order

Answer some eligibility questions and submit payment.
Order now.

2. Test authorization

An independent healthcare provider will review your responses and, if appropriate, authorize your test.

3. Blood draw

A certified phlebotomist will draw your blood.

4. Results

Adaptive will process the blood sample and share results with you via a secure email from PWNHealth.

Estimated time for test results is 7-10 days from shipment of blood sample (including 5-7 days for lab processing*).

Adaptive has partnered with PWNHealth, an independent healthcare provider network, to authorize tests, when appropriate.

*Lab processing begins once all required provider and patient information is validated.

Why T cells?

  • T cells are the first responders of the adaptive immune system.
  • T cell responses persist in the blood long after antibody responses wane.1, 2
  • High specificity: T cells can detect 70% of the parts of the virus, while antibodies can only detect 30%.3

T cells vs. antibodies

  • In studies, the T-Detect COVID test outperformed leading antibody tests.5

Sensitivity based on Positive Percent Agreement (PPA) with PCR testing.
Sensitivity is the ability of a test to correctly determine if a person has or had the disease.

Frequently asked questions

How does T-Detect COVID work?

T cells are the first responders of the adaptive immune system and activate the antibody response. While antibodies to SARS-CoV-2 (the virus that causes the COVID-19 disease) naturally wane and are detectable in the shorter term, T cell responses can persist in the blood long after antibody responses wane.1,2,4

The T-Detect COVID test can detect T cells in a blood sample that can remain for up to several months after symptoms appear.1,2,3

  1. Zuo J, et al. Robust SARS-CoV-2-specific T-cell immunity is maintained at six months following primary infection. bioRxiv. 2020.
  2. Adaptive data on file.
  3. Ng, O, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016.
  4. Dalai, D, et al. Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection. medRxiv. 2020.

In vitro diagnostic for prescription use only. This test has not been cleared or approved by the FDA. The T-Detect COVID assay is available for use as a CLIA-validated laboratory developed test (LDT). T-Detect COVID is not indicated for use in patients under age 18.

For Physicians

The T-Detect COVID test can capture past COVID-19 infections that may be missed by serology testing.

Learn more

For Employers

The T-Detect COVID test can help your employees get the answers they need.

For Researchers

The T-Detect COVID test can support your research due to its high sensitivity and specificity.

References

  1. Tay MZ, et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020.
  2. Ng O, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016.
  3. Zuo J, et al. Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection. bioRxiv. 2020.
  4. Channappanavar R, et al. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014.
  5. Dalai S, et al. Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection. medRxiv. 2021.
  6. Adaptive data on file.